{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T07:54:04Z","timestamp":1781855644513,"version":"3.54.5"},"reference-count":56,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMM"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Alternative splicing (AS) events significantly affect melanoma\nprogression. Therefore, understanding their effect on prognosis is important for\ndeveloping new treatments.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Univariate Cox regression analysis and LASSO regression were carried out\nto identify key AS events, build an AS risk model, and classify sample risk levels.\nPearson correlation analysis was also performed to analyze the relationship between\nAS events and RNA-binding protein (RBP) genes or indicators of immune infiltration.\nKyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses\nwere performed using gene expression data from patients with varying risk levels.\nUnivariate and multivariable Cox regression analyses were also carried out to examine\nthe association between immune cell infiltration and prognosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>A total of 41446 AS events were identified; among them, 446 AS events were\nidentified as significantly associated with melanoma prognosis. An AS risk model for\nprognosis was established using seven key AS events. A close correlation was found\nbetween 137 AS events and 1037 RBP genes, suggesting that these genes may\nparticipate in the regulation of AS events. KEGG enrichment analysis revealed that the\ngenes involved in AS were closely associated with immune system functions, which\nmay explain why AS events affect the prognosis of melanoma. Finally, by combining\nthe AS risk score and clinical indicators, we developed a nomogram model that could\neffectively predict melanoma prognosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This analysis of AS events and regulation may aid in developing novel\nprognostic biomarkers and therapeutic targets for melanoma.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0115665240355992250311071633","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T08:01:36Z","timestamp":1744099296000},"page":"268-283","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Analysis of Alternative Splicing Events in Melanoma and the Implications for Prognosis"],"prefix":"10.2174","volume":"26","author":[{"given":"Hongwei","family":"Deng","sequence":"first","affiliation":[{"name":"Department of Anesthesiology, the Affiliated Hospital, Southwest Medical University, Luzhou, SichuanProvince, 646000, China"},{"name":"Anesthesiology and Critical Care Medicine Key Laboratory of Luzhou, the AffiliatedHospital, Southwest Medical University, Luzhou, Sichuan Province, 646000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou Province, 550004, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, the Affiliated Hospital, Southwest Medical University, Luzhou, SichuanProvince, 646000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, the Affiliated Hospital, Southwest Medical University, Luzhou, SichuanProvince, 646000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianglin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pain Management, The Affiliated Hospital, Southwest Medical University, Luzhou,646000, Sichuan, China"},{"name":"Department of Anesthesiology, Hejiang County People's Hospital, SouthwestMedical University, Luzhou, 646200, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, the Affiliated Hospital, Southwest Medical University, Luzhou, SichuanProvince, 646000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajun","family":"Yu","sequence":"additional","affiliation":[{"name":"Nucleic Acid Medicine of Luzhou Key Laboratory, Southwest Medical University, Luzhou, Sichuan Province, 646000, China"},{"name":"Key Laboratory of Medical Electrophysiology, Ministry of Education, Institute of Cardiovascular Research and Institute of Metabolic Diseases, Southwest Medical University, Luzhou, Sichuan, 646000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianguo","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, the Affiliated Hospital, Southwest Medical University, Luzhou, SichuanProvince, 646000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijing","family":"He","sequence":"additional","affiliation":[{"name":"Laboratory of NeurologicalDiseases and Brain Function, The Affiliated Hospital of Southwest Medical University, Luzhou, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.cps.2021.05.001","volume":"48","author":"Dzwierzynski W.W.","year":"2021","unstructured":"Dzwierzynski W.W.; Melanoma risk factors and prevention. Clin Plast Surg  2021,48(4),543-550","journal-title":"Clin Plast Surg"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1001\/jamadermatol.2022.0160","volume":"158","author":"Arnold M.","year":"2022","unstructured":"Arnold M.; Singh D.; Laversanne M.; Global burden of cutaneous melanoma in 2020 and projections to 2040. JAMA Dermatol  2022,158(5),495-503","journal-title":"JAMA Dermatol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1080\/07853890.2022.2026001","volume":"54","author":"Rousi E.K.","year":"2022","unstructured":"Rousi E.K.; Kallionp\u00e4 R.A.; Kallionp\u00e4 R.E.; Increased incidence of melanoma in children and adolescents in Finland in 1990\u20132014: Nationwide re-evaluation of histo-pathological characteristics. Ann Med  2022,54(1),244-252","journal-title":"Ann Med"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.abd.2020.08.002","volume":"96","author":"Brown R.V.S.","year":"2021","unstructured":"Brown R.V.S.; Hillesheim D.; Tomasi Y.T.; Nunes D.H.; Mortality from malignant skin melanoma in elderly Brazilians: 2001 to 2016. An Bras Dermatol  2021,96(1),34-39","journal-title":"An Bras Dermatol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"16118","DOI":"10.3390\/ijerph192316118","volume":"19","author":"Dziankowska-Zaborszczyk E.","year":"2022","unstructured":"Dziankowska-Zaborszczyk E.; Maniecka-Bry\u0142a I.; Pikala M.; Mortality trends due to skin melanoma in poland in the years 2000\u20132020. Int J Environ Res Publ Heal  2022,19(23),16118","journal-title":"Int J Environ Res Publ Heal"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"Siegel R.L.","year":"2024","unstructured":"Siegel R.L.; Giaquinto A.N.; Jemal A.; Cancer statistics, 2024. CA Cancer J Clin  2024,74(1),12-49","journal-title":"CA Cancer J Clin"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cancergen.2024.06.002","volume":"286-287","author":"Sonkin D.","year":"2024","unstructured":"Sonkin D.; Thomas A.; Teicher B.A.; Cancer treatments: Past, present, and future. Cancer Genet  2024,286-287,18-24","journal-title":"Cancer Genet"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41392-021-00827-6","volume":"6","author":"Guo W.","year":"2021","unstructured":"Guo W.; Wang H.; Li C.; Signal pathways of melanoma and targeted therapy. Signal Transduct Target Ther  2021,6(1),424","journal-title":"Signal Transduct Target Ther"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"10732748211051554","DOI":"10.1177\/10732748211051554","volume":"29","author":"Huang R.","year":"2022","unstructured":"Huang R.; Li M.; Zeng Z.; The identification of prognostic and metastatic alternative splicing in skin cutaneous melanoma. Cancer Contr  2022,29,10732748211051554","journal-title":"Cancer Contr"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"e1010065","DOI":"10.1371\/journal.pcbi.1010065","volume":"18","author":"Holland D.O.","year":"2022","unstructured":"Holland D.O.; Gotea V.; Fedkenheuer K.; Characterization and clustering of kinase isoform expression in metastatic melanoma. PLOS Comput Biol  2022,18(5),e1010065","journal-title":"PLOS Comput Biol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s12672-022-00506-0","volume":"13","author":"Zhang D.","year":"2022","unstructured":"Zhang D.; Lu W.; Zhuo Z.; Mei H.; Wu X.; Cui Y.; Construction of a breast cancer prognosis model based on alternative splicing and immune infiltration. Discover Oncology  2022,13(1),78","journal-title":"Discover Oncology"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"993","DOI":"10.3390\/biom12070993","volume":"12","author":"Bokharaie H.","year":"2022","unstructured":"Bokharaie H.; Kolch W.; Krstic A.; Analysis of alternative mRNA splicing in vemurafenib-resistant melanoma cells. Biomolecules  2022,12(7),993","journal-title":"Biomolecules"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.celrep.2018.01.088","volume":"23","author":"Seiler M.","year":"2018","unstructured":"Seiler M.; Peng S.; Agrawal A.A.; Somatic mutational landscape of splicing factor genes and their functional consequences across 33 cancer types. Cell Rep  2018,23(1),282-296.e4","journal-title":"Cell Rep"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/ng.2523","volume":"45","author":"Harbour J.W.","year":"2013","unstructured":"Harbour J.W.; Roberson E.D.O.; Anbunathan H.; Onken M.D.; Worley L.A.; Bowcock A.M.; Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma. Nat Genet  2013,45(2),133-135","journal-title":"Nat Genet"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"663495","DOI":"10.3389\/fimmu.2021.663495","volume":"12","author":"Liu D.","year":"2021","unstructured":"Liu D.; Yang X.; Wu X.; Tumor immune microenvironment characterization identifies prognosis and immunotherapy-related gene signatures in melanoma. Front Immunol  2021,12,663495","journal-title":"Front Immunol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/j.1600-065X.2008.00662.x","volume":"224","author":"Fife B.T.","year":"2008","unstructured":"Fife B.T.; Bluestone J.A.; Control of peripheral T\u2010cell tolerance and autoimmunity via the CTLA\u20104 and PD\u20101 pathways. Immunol Rev  2008,224(1),166-182","journal-title":"Immunol Rev"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1038\/labinvest.2017.64","volume":"97","author":"Kaunitz G.J.","year":"2017","unstructured":"Kaunitz G.J.; Cottrell T.R.; Lilo M.; Melanoma subtypes demonstrate distinct PD-L1 expression profiles. Lab Invest  2017,97(9),1063-1071","journal-title":"Lab Invest"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"14324","DOI":"10.1073\/pnas.1311839110","volume":"110","author":"Ergun A.","year":"2013","unstructured":"Ergun A.; Doran G.; Costello J.C.; Differential splicing across immune system lineages. Proc Natl Acad Sci USA  2013,110(35),14324-14329","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/wrna.1335","volume":"7","author":"Chang X.","year":"2016","unstructured":"Chang X.; RNA \u2010binding protein hnRNPLL as a critical regulator of lymphocyte homeostasis and differentiation. Wiley Interdiscip Rev RNA  2016,7(3),295-302","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"5666","DOI":"10.1093\/nar\/gks221","volume":"40","author":"Preu\u00dfner M.","year":"2012","unstructured":"Preu\u00dfner M.; Schreiner S.; Hung L.H.; HnRNP L and L-like cooperate in multiple-exon regulation of CD45 alternative splicing. Nucleic Acids Res  2012,40(12),5666-5678","journal-title":"Nucleic Acids Res"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"11292","DOI":"10.1038\/ncomms11292","volume":"7","author":"Meininger I.","year":"2016","unstructured":"Meininger I.; Griesbach R.A.; Hu D.; Alternative splicing of MALT1 controls signalling and activation of CD4+ T cells. Nat Commun  2016,7(1),11292","journal-title":"Nat Commun"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"D1018","DOI":"10.1093\/nar\/gkv1288","volume":"44","author":"Ryan M.","year":"2016","unstructured":"Ryan M.; Wong W.C.; Brown R.; TCGASpliceSeq a compendium of alternative mRNA splicing in cancer. Nucleic Acids Res  2016,44(D1),D1018-D1022","journal-title":"Nucleic Acids Res"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jclinepi.2022.01.011","volume":"145","author":"Berkelmans G.F.N.","year":"2022","unstructured":"Berkelmans G.F.N.; Read S.H.; Gudbj\u00f6rnsdottir S.; Population median imputation was noninferior to complex approaches for imputing missing values in cardiovascular prediction models in clinical practice. J Clin Epidemiol  2022,145,70-80","journal-title":"J Clin Epidemiol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1093\/bioinformatics\/btx364","volume":"33","author":"Conway J.R.","year":"2017","unstructured":"Conway J.R.; Lex A.; Gehlenborg N.; UpSetR: An R package for the visualization of intersecting sets and their properties. Bioinformatics  2017,33(18),2938-2940","journal-title":"Bioinformatics"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13000-023-01414-9","volume":"19","author":"Xiong T.","year":"2024","unstructured":"Xiong T.; Wang Y.; Zhu C.; A risk model based on 10 ferroptosis regulators and markers established by LASSO-regularized linear Cox regression has a good prognostic value for ovarian cancer patients. Diagn Pathol  2024,19(1),4","journal-title":"Diagn Pathol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"105948","DOI":"10.1016\/j.ijsu.2021.105948","volume":"89","author":"Tang G.","year":"2021","unstructured":"Tang G.; Qi L.; Sun Z.; Evaluation and analysis of incidence and risk factors of lower extremity venous thrombosis after urologic surgeries: A prospective two-center cohort study using LASSO-logistic regression. Int J Surg  2021,89,105948","journal-title":"Int J Surg"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"e23503","DOI":"10.1016\/j.heliyon.2023.e23503","volume":"10","author":"Ding G.","year":"2024","unstructured":"Ding G.; Wang T.; Tang G.; Zou Q.; Wu G.; Wu J.; A novel prognostic predictor of immune microenvironment and therapeutic response in clear cell renal cell carcinoma based on angiogenesis\u2013immune-related gene signature. Heliyon  2024,10(1),e23503","journal-title":"Heliyon"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00262-024-03725-2","volume":"73","author":"Zhou Y.","year":"2024","unstructured":"Zhou Y.; Chu L.; Li S.; Prognostic value of genomic mutation signature associated with immune microenviron-ment in southern Chinese patients with esophageal squamous cell carcinoma. Cancer Immunol Immunother  2024,73(8),141","journal-title":"Cancer Immunol Immunother"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"D307","DOI":"10.1093\/nar\/gkz823","volume":"48","author":"Liao J.Y.","year":"2020","unstructured":"Liao J.Y.; Yang B.; Zhang Y.C.; EuRBPDB: A comprehensive resource for annotation, functional and oncological investigation of eukaryotic RNA binding proteins (RBPs). Nucleic Acids Res  2020,48(D1),D307-D313","journal-title":"Nucleic Acids Res"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1186\/1752-0509-8-S4-S11","volume":"8","author":"Chin C-H.","year":"2014","unstructured":"Chin C-H.; Chen S-H.; Wu H-H.; Ho C-W.; Ko M-T.; Lin C-Y.; cytoHubba: Identifying hub objects and sub-networks from complex interactome. BMC Syst Biol  2014,8(Suppl. 4),S11","journal-title":"BMC Syst Biol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1200\/CCI.20.00059","volume":"4","author":"Osterman T.J.","year":"2020","unstructured":"Osterman T.J.; Terry M.; Miller R.S.; Improving cancer data interoperability: The promise of the minimal common oncology data elements (mCODE) initiative. JCO Clin Cancer Inform  2020,4(4),993-1001","journal-title":"JCO Clin Cancer Inform"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1002\/imt2.36","volume":"1","author":"Shen W.","year":"2022","unstructured":"Shen W.; Song Z.; Zhong X.; Sangerbox: A comprehensive, interaction\u2010friendly clinical bioinformatics analysis platform. iMeta  2022,1(3),e36","journal-title":"iMeta"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s12920-019-0635-z","volume":"12","author":"Jin Y.J.","year":"2019","unstructured":"Jin Y.J.; Byun S.; Han S.; Differential alternative splicing regulation among hepatocellular carcinoma with different risk factors. BMC Med Genomics  2019,12(S8)(Suppl. 8),175","journal-title":"BMC Med Genomics"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/BF00208276","volume":"94","author":"Rootwelt H.","year":"1994","unstructured":"Rootwelt H.; Kristensen T.; Berger R.; H\u00f8ie K.; Kvittingen E.A.; Tyrosinemia type 1--complex splicing defects and a missense mutation in the fumarylacetoacetase gene. Hum Genet  1994,94(3),235-239","journal-title":"Hum Genet"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41568-021-00339-z","volume":"21","author":"Jhunjhunwala S.","year":"2021","unstructured":"Jhunjhunwala S.; Hammer C.; Delamarre L.; Antigen presentation in cancer: Insights into tumour immunogenicity and immune evasion. Nat Rev Cancer  2021,21(5),298-312","journal-title":"Nat Rev Cancer"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/s12964-023-01236-8","volume":"21","author":"Lin W.","year":"2023","unstructured":"Lin W.; Fang J.; Wei S.; Extracellular vesicle-cell adhesion molecules in tumours: Biofunctions and clinical applications. Cell Commun Signal  2023,21(1),246","journal-title":"Cell Commun Signal"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1045130","DOI":"10.3389\/fcell.2022.1045130","volume":"10","author":"Luo J.","year":"2023","unstructured":"Luo J.; Chen C.; Liu Z.; Wang X.; The mutation in splicing factor genes correlates with unfavorable prognosis, genomic instability, anti-tumor immunosuppression and increased immunotherapy response in pan-cancer. Front Cell Dev Biol  2023,10,1045130","journal-title":"Front Cell Dev Biol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/s10142-024-01443-7","volume":"24","author":"Liu H.","year":"2024","unstructured":"Liu H.; Weng J.; Huang C.L.H.; Jackson A.P.; Is the voltage-gated sodium channel \u03b23 subunit (SCN3B) a biomarker for glioma? Funct Integr Genomics  2024,24(5),162","journal-title":"Funct Integr Genomics"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"146325","DOI":"10.1016\/j.gene.2022.146325","volume":"822","author":"Liu H.","year":"2022","unstructured":"Liu H.; Weng J.; A comprehensive bioinformatic analysis of cyclin-dependent kinase 2 (CDK2) in glioma. Gene  2022,822,146325","journal-title":"Gene"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/s41408-022-00759-6","volume":"12","author":"Aktas Samur A.","year":"2022","unstructured":"Aktas Samur A.; Fulciniti M.; Avet-Loiseau H.; In-depth analysis of alternative splicing landscape in multiple myeloma and potential role of dysregulated splicing factors. Blood Cancer J  2022,12(12),171","journal-title":"Blood Cancer J"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.2217\/fon-2020-1191","volume":"17","author":"Yang Y.","year":"2021","unstructured":"Yang Y.; Jia J.; Sun Z.; Polymorphism of FGD4 and myelosuppression in patients with esophageal squamous cell carcinoma. Future Oncol  2021,17(18),2351-2363","journal-title":"Future Oncol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1042\/CS20191043","volume":"134","author":"Dai X.","year":"2020","unstructured":"Dai X.; Liu J.; Guo X.; Circular RNA circFGD4 suppresses gastric cancer progression via modulating miR-532-3p\/APC\/\u03b2-catenin signalling pathway. Clin Sci (Lond)  2020,134(13),1821-1839","journal-title":"Clin Sci (Lond)"},{"key":"ref=43","first-page":"2768","volume":"10","author":"Zhou C.","year":"2020","unstructured":"Zhou C.; Weng J.; Liu C.; High RPS3A expression correlates with low tumor immune cell infiltration and unfavorable prognosis in hepatocellular carcinoma patients. Am J Cancer Res  2020,10(9),2768-2784","journal-title":"Am J Cancer Res"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"110914","DOI":"10.1016\/j.cellsig.2023.110914","volume":"112","author":"Li Z.","year":"2023","unstructured":"Li Z.; Zhang M.; Chen S.; BTN3A3 inhibits clear cell renal cell carcinoma progression by regulating the ROS\/MAPK pathway via interacting with RPS3A. Cell Signal  2023,112,110914","journal-title":"Cell Signal"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"8755","DOI":"10.7150\/thno.63446","volume":"11","author":"Park S.Y.","year":"2021","unstructured":"Park S.Y.; Kim J.Y.; Jang G.B.; Aberrant activation of the CD45-Wnt signaling axis promotes stemness and therapy resistance in colorectal cancer cells. Theranostics  2021,11(18),8755-8770","journal-title":"Theranostics"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"7965","DOI":"10.1038\/s41598-022-11697-5","volume":"12","author":"Saliani M.","year":"2022","unstructured":"Saliani M.; Jalal R.; Javadmanesh A.; Differential expression analysis of genes and long non-coding RNAs associated with KRAS mutation in colorectal cancer cells. Sci Rep  2022,12(1),7965","journal-title":"Sci Rep"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1145481","DOI":"10.3389\/fimmu.2023.1145481","volume":"14","author":"Li P.","year":"2023","unstructured":"Li P.; Wang W.; Wang S.; PTPRC promoted CD8+ T cell mediated tumor immunity and drug sensitivity in breast cancer: Based on pan-cancer analysis and artificial intelligence modeling of immunogenic cell death-based drug sensitivity stratification. Front Immunol  2023,14,1145481","journal-title":"Front Immunol"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"1755214","DOI":"10.1080\/2162402X.2020.1755214","volume":"9","author":"Pol J.G.","year":"2020","unstructured":"Pol J.G.; Le Naour J.; Kroemer G.; FLT3LG - a biomarker reflecting clinical responses to the immunogenic cell death inducer oxaliplatin. OncoImmunology  2020,9(1),1755214","journal-title":"OncoImmunology"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"111280","DOI":"10.1016\/j.intimp.2023.111280","volume":"126","author":"Wang X.","year":"2024","unstructured":"Wang X.; Yan L.; Guo J.; Jia R.; An anti-PD-1 antisense oligonucleotide promotes the expression of soluble PD-1 by blocking the interaction between SRSF3 and an exonic splicing enhancer of PD-1 exon 3. Int Immunopharmacol  2024,126,111280","journal-title":"Int Immunopharmacol"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"e497","DOI":"10.1016\/j.clbc.2020.11.006","volume":"21","author":"Han Y.","year":"2021","unstructured":"Han Y.; Wang J.; Sun Y.; Prognostic model and nomogram for estimating survival of small breast cancer: A seer-based analysis. Clin Breast Cancer  2021,21(5),e497-e505","journal-title":"Clin Breast Cancer"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"34","DOI":"10.7150\/jca.100922","volume":"16","author":"Liu H.","year":"2025","unstructured":"Liu H.; Li Y.; Karsidag M.; Tu T.; Wang P.; Technical and biological biases in bulk transcriptomic data mining for cancer research. J Cancer  2025,16(1),34-43","journal-title":"J Cancer"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"102042","DOI":"10.1016\/j.genrep.2024.102042","volume":"37","author":"Liu H.","year":"2024","unstructured":"Liu H.; Guo Z.; Wang P.; Genetic expression in cancer research: Challenges and complexity. Gene Rep  2024,37,102042","journal-title":"Gene Rep"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1093\/ibd\/izab187","volume":"28","author":"Javaid A.","year":"2022","unstructured":"Javaid A.; Shahab O.; Adorno W.; Fernandes P.; May E.; Syed S.; Machine learning predictive outcomes modeling in inflammatory bowel diseases. Inflamm Bowel Dis  2022,28(6),819-829","journal-title":"Inflamm Bowel Dis"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"872186","DOI":"10.3389\/fgene.2022.872186","volume":"13","author":"Maimaiti A.","year":"2022","unstructured":"Maimaiti A.; Tuersunniyazi A.; Meng X.; N6-methyladenosine RNA methylation regulator-related alternative splicing gene signature as prognostic predictor and in immune microenvironment characterization of patients with low-grade glioma. Front Genet  2022,13,872186","journal-title":"Front Genet"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"657087","DOI":"10.3389\/fmolb.2021.657087","volume":"8","author":"Zhao Z.","year":"2021","unstructured":"Zhao Z.; Cai Q.; Zhang P.; N6-methyladenosine RNA methylation regulator-related alternative splicing (AS) gene signature predicts non\u2013small cell lung cancer prognosis. Front Mol Biosci  2021,8,657087","journal-title":"Front Mol Biosci"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s13073-021-00930-x","volume":"13","author":"Poirion O.B.","year":"2021","unstructured":"Poirion O.B.; Jing Z.; Chaudhary K.; Huang S.; Garmire L.X.; DeepProg: An ensemble of deep-learning and machine-learning models for prognosis prediction using multi-omics data. Genome Med  2021,13(1),112","journal-title":"Genome Med"}],"container-title":["Current Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115665240355992250311071633","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/240778\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115665240355992250311071633","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T07:32:03Z","timestamp":1781854323000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/240778\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0115665240355992250311071633","relation":{},"ISSN":["1566-5240"],"issn-type":[{"value":"1566-5240","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-10-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-26","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}